The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campanella, G. S. V.
Right arrow Articles by Luster, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campanella, G. S. V.
Right arrow Articles by Luster, A. D.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2006, 177: 6991-6998.
Copyright © 2006 by The American Association of Immunologists, Inc.

Oligomerization of CXCL10 Is Necessary for Endothelial Cell Presentation and In Vivo Activity1

Gabriele S. V. Campanella*, Jan Grimm{dagger}, Lindsay A. Manice*, Richard A. Colvin*, Benjamin D. Medoff*, Gregory R. Wojtkiewicz{dagger}, Ralph Weissleder{dagger} and Andrew D. Luster2,*

* Division of Rheumatology, Allergy, and Immunology, Center for Immunology and Inflammatory Diseases, and {dagger} Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129

The chemokine IFN-{gamma}-inducible protein of 10 kDa (IP-10; CXCL10) plays an important role in the recruitment of activated T lymphocytes into sites of inflammation by interacting with the G protein-coupled receptor CXCR3. IP-10, like other chemokines, forms oligomers, the role of which has not yet been explored. In this study, we used a monomeric IP-10 mutant to elucidate the functional significance of oligomerization. Although monomeric IP-10 had reduced binding affinity for CXCR3 and heparin, it was able to induce in vitro chemotaxis of activated T cells with the same efficacy as wild-type IP-10. However, monomeric IP-10 was unable to induce recruitment of activated CD8+ T cells into the airways of mice after intratracheal instillation. Use of a different IP-10 mutant demonstrated that this inability was due to lack of oligomerization rather than reduced CXCR3 or heparin binding. Molecular imaging demonstrated that both wild-type and monomeric IP-10 were retained in the lung after intratracheal instillation. However, in vitro binding assays indicated that wild-type, but not monomeric, IP-10 was retained on endothelial cells and could induce transendothelial chemotaxis of activated T cells. We therefore propose that oligomerization of IP-10 is required for presentation on endothelial cells and subsequent transendothelial migration, an essential step for lymphocyte recruitment in vivo.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grant RO1-CA69212 (to A.D.L.) and R24-CA92782 (to R.W.).

2 Address correspondence and reprint requests to Dr. Andrew D. Luster, Massachusetts General Hospital, Building 149, 13th Street, Charlestown, MA 02129. E-mail address: luster.andrew{at}mgh.harvard.edu

3 Abbreviations used in this paper: IP-10, IFN-{gamma}-inducible protein of 10 kDa; GAG, glycosaminoglycan; HMEC, human microvascular endothelial cells; CHO, Chinese hamster ovary; BAL, bronchoalveolar lavage; DTPA, diethylenetriaminepentaacetic; CT, computed tomography; SPECT, single-photon emission CT; Sulfo-EGS, sulfo-ethylene glycolbis(sulfosuccinimidylsuccinate); BS3, bis(sulfosuccinimidyl)suberate.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. Karlsson, M. Eliasson, A. I. Olin, M. Morgelin, A. Karlsson, M. Malmsten, A. Egesten, and I.-M. Frick
SufA of the Opportunistic Pathogen Finegoldia magna Modulates Actions of the Antibacterial Chemokine MIG/CXCL9, Promoting Bacterial Survival during Epithelial Inflammation
J. Biol. Chem., October 23, 2009; 284(43): 29499 - 29508.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
D. Vindrieux, P. Escobar, and G. Lazennec
Emerging roles of chemokines in prostate cancer
Endocr. Relat. Cancer, September 1, 2009; 16(3): 663 - 673.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. R. Wuest and D. J. J. Carr
Dysregulation of CXCR3 Signaling due to CXCL10 Deficiency Impairs the Antiviral Response to Herpes Simplex Virus 1 Infection
J. Immunol., December 1, 2008; 181(11): 7985 - 7993.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Loos, A. Mortier, M. Gouwy, I. Ronsse, W. Put, J.-P. Lenaerts, J. Van Damme, and P. Proost
Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation
Blood, October 1, 2008; 112(7): 2648 - 2656.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
C. T. Veldkamp, C. Seibert, F. C. Peterson, N. B. De la Cruz, J. C. Haugner III, H. Basnet, T. P. Sakmar, and B. F. Volkman
Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12
Sci. Signal., September 16, 2008; 1(37): ra4 - ra4.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
F. Dominguez, S. Martinez, A. Quinonero, F. Loro, J.A. Horcajadas, A. Pellicer, and C. Simon
CXCL10 and IL-6 induce chemotaxis in human trophoblast cell lines
Mol. Hum. Reprod., July 1, 2008; 14(7): 423 - 430.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Kwun, H. Hu, E. Schadde, D. Roenneburg, K. A. Sullivan, J. DeMartino, W. J. Burlingham, and S. J. Knechtle
Altered Distribution of H60 Minor H Antigen-Specific CD8 T Cells and Attenuated Chronic Vasculopathy in Minor Histocompatibility Antigen Mismatched Heart Transplantation in Cxcr3 / Mouse Recipients
J. Immunol., December 15, 2007; 179(12): 8016 - 8025.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.